In Congo Outbreak, Ebola Vaccine Faces Cold-Chain Reality Tests
Supply Chain Brain
MAY 23, 2018
Because it is not yet licensed, the Merck & Co vaccine has been offered to Congo under a “compassionate use” protocol agreed by national and international health and ethics authorities. The Congo outbreak is a chance to reality-test a vaccine against a disease epidemic that can’t be replicated in controlled environments.